Related Experiment Video
Updated: Jan 6, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Identification of Drug Targets in Breast Cancer Metabolic Network
Krishna Kanhaiya1,2, Dwitiya Tyagi-Tiwari1,2
1Computational Biomodeling Laboratory, Turku Centre for Computer Science, Turku, Finland.
Abstract:
Genome-scale metabolic models have been proven to be valuable for defining cancer or to indicate the severity of cancer. However, identifying effective metabolic drug target (DT) of the active small-molecule compound is difficult to unravel and needs to be investigated. In this study, we identify effective DT for breast cancer using proposed network analysis of enzyme-centric network in the metabolic model. Our network-based analysis revealed that high degree nodes (HDNs) of enzymes are key to progression/development of cancer. These HDNs show high interconnections inside the network. It has been found that these HDNs are crucial driver nodes for effectively targeting in breast cancer metabolic network. Furthermore, based on the correlation and principal component analysis, we have shown that certain proteins play a significant role in the network and can be used as an effective DT in cancer therapeutics. In addition, these proteins stimulate the active site of enzymes to activate the target metabolites. Overall, we have shown that a better understanding of the metabolic networks using statistical model could be valuable in DT identification for developing effective therapeutic approaches and personalized medicine.
Insights
Identifying effective drug targets in breast cancer metabolism is challenging. This study used network analysis to find key enzymes (high degree nodes) and proteins crucial for targeting cancer, paving the way for new therapeutics.
Area of Science:
- Metabolic Engineering
- Computational Biology
- Cancer Research
Background:
- Genome-scale metabolic models aid in understanding cancer.
- Identifying effective metabolic drug targets (DTs) for small-molecule compounds remains a challenge.
Purpose of the Study:
- To identify effective drug targets for breast cancer using network analysis of metabolic models.
- To investigate the role of enzyme-centric networks in cancer progression.
Main Methods:
- Network analysis of enzyme-centric metabolic models.
- Identification of high degree nodes (HDNs) as key drivers.
- Correlation and principal component analysis to identify significant proteins.
Main Results:
- High degree nodes (HDNs) in metabolic networks are critical for cancer progression.
- Specific proteins were identified as potential effective drug targets.
- These proteins activate target metabolites by stimulating enzyme active sites.
Conclusions:
- Network analysis of metabolic models offers a valuable approach for drug target identification.
- Statistical modeling of metabolic networks can lead to effective therapeutic strategies.
- This approach supports the development of personalized medicine for cancer treatment.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: